Overview
- 342 inspections across 196 sites are on record.
- 308 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-26.
At a glance
Inspections
342
Sites
196
Observations
308
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| CSL Plasma Inc. | 26 Jun 2026 | Biologics | |
| OneBlood; Inc | 23 Jun 2026 | Biologics | |
| Creative Testing Solutions | 4 Jun 2026 | Biologics | |
| Blood Connection Inc. (The) | 19 May 2026 | Biologics | |
| American Red Cross Blood Svcs | 18 May 2026 | Biologics | View 483 → |
Sites inspected
CSL Plasma Inc.Gastonia, United States1 insp.
OneBlood; IncGastonia, United States1 insp.
Creative Testing SolutionsCharlotte, United States1 insp.
Blood Connection Inc. (The)Arden, United States1 insp.
American Red Cross Blood SvcsAsheville, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Kimberly C Delk-Brooks18 shared
Cordelia J Brammer17 shared
Marla A Cassidy15 shared
Esra Toussaint13 shared
Michelle D Haamid9 shared
Hristu B Chepa8 shared
Brian A Graves6 shared
Kip J Hanks6 shared
Brandy Davis Brown6 shared
Dellarese L Herbert6 shared
Full investigator report
Get the verbatim findings behind Randy L Clarida's 308 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site